LAMP1 and plasma cell myeloma: For matched NK cells, the percentage of CD107a+ cells in response to myeloma target cells was 10.6 % with U266, 7.8 % with L-363, 6.4 % with RPMI-8226/S and 24 % with OPM-1 (Fig. 4b).